Changes in body composition as assessed by DXA scan after one year of high dose growth hormone treatment in children born SGA. Results from the NESGAS group

被引：0

作者：

O'Connell, Susan M. ^{[1
,2
]}

Jensen, Rikke Beck ^{[3
]}

Salgin, Burak ^{[4
]}

O'Mullane, Elaine ^{[1
]}

Kirk, Jeremy ^{[5
]}

Donaldson, Malcolm ^{[6
]}

Ivarsson, Sten ^{[7
]}

Soder, Olle ^{[8
,9
]}

Dunger, David B. ^{[4
]}

Juul, Anders ^{[3
]}

Hoey, Hilary M. C. V. ^{[1
,2
]}

机构：

[1] Natl Childrens Hosp, Dublin, Ireland

[2] Univ Dublin Trinity Coll, Dublin 2, Ireland

[3] Rigshosp, DK-2100 Copenhagen, Denmark

[4] Univ Cambridge, Addenbrookes Hosp, Cambridge CB2 2QQ, England

[5] Birmingham Childrens Hosp, Birmingham, W Midlands, England

[6] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland

[7] Univ Sjukhuset MAS, Malmo, Sweden

[8] Karolinska Inst, Pediat Endocrinol Unit, Stockholm, Sweden

[9] Univ Hosp, Stockholm, Sweden

来源：

HORMONE RESEARCH | 2009年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：445 / 445

页数：1

共 26 条

[21] Age and Severity of Growth Retardation at Treatment Start, but Not Degree of Prematurity or IUGR Are Related to One and Two Year GH Treatment Response in Short Children Born SGA: Data from the Nordinet® IOS and ANSWER® Program. [J].

Lee, Peter A. ;

Blankenstein, Oliver ;

Pienkowski, Catherine ;

Oliver, Isabelle ;

Snajderova, Marta ;

Rakov, Viatcheslav ;

Pedersen, Birgitte T. ;

Germak, John ;

Savendahl, Lars .

ENDOCRINE REVIEWS, 2010, 31 (03)

[22] Insulin-like growth factor-I, d3-GHR gene polymorphism, prematurity and height at start as determinants of one year growth response during high dose GH; preliminary results from the NESGA study (NESGAS) [J].

Jensen, Rikke B. ;

O'Connell, Susan ;

Salgin, Burak ;

Kirk, Jeremy ;

Donaldson, Malcolm ;

Ivarsson, Sten ;

Soder, Olle ;

Hoey, Hilary ;

Dunger, David B. ;

Juul, Anders .

HORMONE RESEARCH, 2009, 72 :440-440

[23] In children suffering from juvenile idiopathic arthritis, RHGH treatment, started one year after the initiation of glucocorticoid therapy prevents growth retardation and increases lean body mass: Results of a 3-year randomised controlled study [J].

Simon, D. ;

Ruiz, J. ;

Prieur, A. ;

Czernichow, P. .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 :568-568

[24] Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: Results of a randomized, double-blind, dose-response GH trial [J].

van Pareren, Y ;

Mulder, P ;

Houdijk, M ;

Jansen, M ;

Reeser, M ;

Hokken-Koelega, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (08) :3584-3590

[25] Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial [J].

Willemsen, Ruben H. ;

Arends, Nicolette J. T. ;

Waarde, Willie M. Bakker-van ;

Jansen, Maarten ;

van Mil, Edgar G. A. H. ;

Mulder, Jaap ;

Odink, Roelof J. ;

Reeser, Maarten ;

Rongen-Westerlaken, Ciska ;

Stokvis-Brantsma, Wilhelmina H. ;

Waelkens, Johan J. J. ;

Hokken-Koelega, Anita C. S. .

CLINICAL ENDOCRINOLOGY, 2007, 67 (04) :485-492

[26] D3-growth hormone receptor polymorphism (d3-GHR) does not influence the effect of GH treatment in prepubertal short SGA children: results from a two-year controlled prospective trial in 68 GH-treated and 72 non GH-treated patients [J].

Carrascosa, Antonio ;

Esteban, Cristina ;

Espadero, Rosa ;

Cancio, Monica Fernandez ;

Andaluz, Pilar ;

Clemente, Maria ;

Audi, Laura ;

Wollmann, Hartmut ;

Frykund, Linda ;

Parodi, Luis A. .

HORMONE RESEARCH, 2006, 65 :153-153

← 1 2 3 →